Search research articles
Contact Us
Filters
Showing results (181-190 of 196) with videos related to
Page
of 20
Sort By:
Urologic Oncology
|
April 4, 2026
Risk stratification of Ta high-grade non-muscle-invasive bladder cancer: Insights from a multicenter cohort study
Paolo Zaurito, Pietro Scilipoti, Mattia Longoni, et al.
European Urology Oncology
|
February 14, 2024
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics
José Daniel Subiela, Wojciech Krajewski, Daniel A González-Padilla, et al.
Urologia Internationalis
|
January 7, 2021
Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages
Sabine Kliesch, Stefanie Schmidt, Doris Wilborn, et al.
Urologia Internationalis
|
January 24, 2021
Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II - Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy
Sabine Kliesch, Stefanie Schmidt, Doris Wilborn, et al.
BJU International
|
March 3, 2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups
Ana Fernández-Mardomingo, Jose Daniel Subiela, Alberto Artiles Medina, et al.
Targeted Oncology
|
October 1, 2024
Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2<sup>EV</sup> Study
Ondřej Fiala, Francesco Massari, Umberto Basso, et al.
World Journal of Urology
|
October 28, 2025
Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study
Mario de Angelis, Francesco Pellegrino, Pietro Scilipoti, et al.
Clinical Genitourinary Cancer
|
April 16, 2023
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)
Matteo Santoni, Francesco Massari, Zin W Myint, et al.
Targeted Oncology
|
June 27, 2023
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study
Matteo Santoni, Francesco Massari, Zin W Myint, et al.
BJU International
|
October 6, 2025
Temporal trends and clinical determinants of urinary diversion after radical cystectomy
Francesco Pellegrino, Mario de Angelis, Pietro Scilipoti, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 196) with videos related to
Sort By:
Page
of 20
Urologic Oncology
|
April 4, 2026
Risk stratification of Ta high-grade non-muscle-invasive bladder cancer: Insights from a multicenter cohort study
Paolo Zaurito, Pietro Scilipoti, Mattia Longoni, et al.
European Urology Oncology
|
February 14, 2024
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics
José Daniel Subiela, Wojciech Krajewski, Daniel A González-Padilla, et al.
Urologia Internationalis
|
January 7, 2021
Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages
Sabine Kliesch, Stefanie Schmidt, Doris Wilborn, et al.
Urologia Internationalis
|
January 24, 2021
Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II - Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy
Sabine Kliesch, Stefanie Schmidt, Doris Wilborn, et al.
BJU International
|
March 3, 2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups
Ana Fernández-Mardomingo, Jose Daniel Subiela, Alberto Artiles Medina, et al.
Targeted Oncology
|
October 1, 2024
Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2<sup>EV</sup> Study
Ondřej Fiala, Francesco Massari, Umberto Basso, et al.
World Journal of Urology
|
October 28, 2025
Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study
Mario de Angelis, Francesco Pellegrino, Pietro Scilipoti, et al.
Clinical Genitourinary Cancer
|
April 16, 2023
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)
Matteo Santoni, Francesco Massari, Zin W Myint, et al.
Targeted Oncology
|
June 27, 2023
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study
Matteo Santoni, Francesco Massari, Zin W Myint, et al.
BJU International
|
October 6, 2025
Temporal trends and clinical determinants of urinary diversion after radical cystectomy
Francesco Pellegrino, Mario de Angelis, Pietro Scilipoti, et al.
Page
of 20